Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Maxam-Gilbert Sequencing01:05

Maxam-Gilbert Sequencing

12.5K
In the same year as the discovery of the Sanger sequencing method, another group of scientists, Allan Maxam and Walter Gilbert, demonstrated their chemical-cleavage method for DNA sequencing. The Maxam-Gilbert method relies on using different chemicals that can cleave the DNA sequence at specific sites, the separation of resulting DNA fragments of variable size using electrophoresis, and deciphering the DNA sequence from the resulting gel bands.
Challenges of the Maxam-Gilbert Method
The...
12.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cell Penetrating Thyclotides Facilitate Efficient Delivery of Bioactive Peptides into Cells.

bioRxiv : the preprint server for biology·2026
Same author

Sustained mucosal delivery of SAMT-247 via an intravaginal ring reduces the risk of SIV<sub>mac251</sub> acquisition in vaccinated macaques.

Cell reports. Medicine·2026
Same author

Multiple Charged Purine (MCP) PNA as a Simple Mode for Cellular Uptake.

ACS polymers Au·2026
Same author

Global Proteomics Investigation of SAMT-247 Targets: An Antiviral Thioester that Acetylates Zinc Finger Proteins.

bioRxiv : the preprint server for biology·2026
Same author

Gamma-FIT-PNAs as sensitive RNA probes.

RSC chemical biology·2026
Same author

RNA detection on a microfluidic platform using Thyclotides.

Sensors and actuators reports·2025

Related Experiment Video

Updated: Jan 9, 2026

Sequence-specific and Selective Recognition of Double-stranded RNAs over Single-stranded RNAs by Chemically Modified Peptide Nucleic Acids
09:04

Sequence-specific and Selective Recognition of Double-stranded RNAs over Single-stranded RNAs by Chemically Modified Peptide Nucleic Acids

Published on: September 21, 2017

9.9K

7-Methylguanine With a Cyclopentane Backbone: A Bright Combination for a FIT-PNA RNA Sensor.

Salam Maree1, Pinaki Chanda1, Sheethal Thomas Mannully1

  • 1The Institute for Drug Research, The School of Pharmacy, The Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel.

British Journal of Biomedical Science
|December 8, 2025
PubMed
Summary

Chemically modified FIT-PNAs (forced intercalation-Peptide Nucleic Acids) show significantly enhanced brightness and specificity for detecting cancer-associated long noncoding RNA (lncRNA CCTA-1) in cells.

Keywords:
BisQFIT-PNARNA biosensorscpG+molecular simulations

More Related Videos

Author Spotlight: Characterizing DNA G-Quadruplex by Bis-3-Chloropiperidine Based Chemical Mapping
05:32

Author Spotlight: Characterizing DNA G-Quadruplex by Bis-3-Chloropiperidine Based Chemical Mapping

Published on: May 12, 2023

1.8K
Kinetic Screening of Nuclease Activity using Nucleic Acid Probes
06:52

Kinetic Screening of Nuclease Activity using Nucleic Acid Probes

Published on: November 1, 2019

8.6K

Related Experiment Videos

Last Updated: Jan 9, 2026

Sequence-specific and Selective Recognition of Double-stranded RNAs over Single-stranded RNAs by Chemically Modified Peptide Nucleic Acids
09:04

Sequence-specific and Selective Recognition of Double-stranded RNAs over Single-stranded RNAs by Chemically Modified Peptide Nucleic Acids

Published on: September 21, 2017

9.9K
Author Spotlight: Characterizing DNA G-Quadruplex by Bis-3-Chloropiperidine Based Chemical Mapping
05:32

Author Spotlight: Characterizing DNA G-Quadruplex by Bis-3-Chloropiperidine Based Chemical Mapping

Published on: May 12, 2023

1.8K
Kinetic Screening of Nuclease Activity using Nucleic Acid Probes
06:52

Kinetic Screening of Nuclease Activity using Nucleic Acid Probes

Published on: November 1, 2019

8.6K

Area of Science:

  • Chemical Biology
  • Molecular Diagnostics
  • Biotechnology

Background:

  • FIT-PNAs (forced intercalation-Peptide Nucleic Acids) offer potential as RNA sensors due to fluorescence enhancement upon hybridization.
  • Existing FIT-PNAs require optimization for increased brightness and specificity in biological applications.

Purpose of the Study:

  • To develop a novel chemical modification strategy for FIT-PNAs to enhance their fluorescence and specificity for RNA detection.
  • To investigate the impact of modifying the guanine base adjacent to the fluorophore on FIT-PNA performance.

Main Methods:

  • Synthesized FIT-PNAs with chemically modified guanine bases (G+, cpG, cpG+) adjacent to the BisQ surrogate base.
  • Tested FIT-PNA performance using synthetic RNA and DNA targets, including sequences with mismatches.
  • Evaluated FIT-PNA fluorescence and specificity in ovarian cancer cells overexpressing CCAT1 using FACS and confocal microscopy.
  • Employed molecular simulations to correlate experimental fluorescence data with molecular interactions.

Main Results:

  • The cpG+ modified FIT-PNA exhibited a two-fold increase in brightness compared to the unmodified guanine base.
  • Modified FIT-PNAs showed increased fluorescence with RNA mismatches, unlike synthetic DNA.
  • The cpG+ modified FIT-PNA successfully generated a bright fluorescent signal in ovarian cancer cells, enabling visualization of CCAT1.
  • Molecular simulations supported the experimental findings regarding fluorescence and mismatch behavior.

Conclusions:

  • Chemical modification of the guanine base adjacent to the fluorophore significantly enhances FIT-PNA brightness and RNA specificity.
  • The cpG+ modification represents a promising advancement for developing highly sensitive and specific RNA sensors for biomedical applications.
  • This strategy holds potential for improved molecular diagnostics and targeted therapies in diseases like cancer.